BRP Group, Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended June 30, 2020. The filing identifies the registrant as BRP Group, Inc. (Nasdaq: BRP).
Business context
BRP is a U.S. insurance distribution and services firm operating through Middle Market, Specialty, MainStreet and Medicare segments. Growth relies substantially on acquisitions (“Partnerships”). In the first half of 2020, BRP completed nine acquisitions for aggregate consideration of approximately $309.4 million.
Financial results and liquidity
| Metric | Q2 2020 | Q2 2019 | Six months 2020 | Six months 2019 |
|---|---|---|---|---|
| Commissions and fees | $51.3m | $33.1m | $105.4m | $62.9m |
| Operating income (loss) | ($6.8m) | $0.7m | ($1.5m) | $12.0m |
| Net income (loss), consolidated | ($7.9m) | ($3.0m) | ($3.2m) | $6.8m |
| Net loss attributable to BRP Group, Inc. | ($3.6m) | $0 | ($2.1m) | $0 |
| Adjusted EBITDA and margin | $8.4m; 16% | $4.6m; 14% | $22.4m; 21% | $14.7m; 23% |
| Operating cash flow | Not presented quarterly | $43.6m | $8.9m |
Q2 revenue increased 55% year over year; first-half revenue increased 68%. Management attributed $12.1 million of Q2 and $34.9 million of first-half revenue growth to acquired businesses, with the remainder attributed to organic growth. Reported organic revenue growth was 19% for Q2 and 12% for the first half. GAAP results were pressured by higher operating costs, amortization and fair-value increases in contingent earnout liabilities. The first-half operating cash-flow increase was attributed in part to higher premiums-payable balances.
At June 30, cash and cash equivalents were $194.4 million, restricted cash was $10.1 million, and revolving-credit borrowings were $226.0 million. Total assets were $869.7 million and total liabilities were $447.0 million. The revolving facility had $400 million of capacity, a September 2024 maturity and a 2.19% applicable rate at quarter-end; BRP reported covenant compliance. In July, BRP repaid $125 million of debt using offering proceeds. The June public offering generated $166.6 million net proceeds before the related LLC-unit repurchase noted in the filing.
Material changes, outlook and risks
- Operating loss and consolidated net loss replaced the prior-year Q2 operating profit; first-half net income also shifted to a loss. Adjusted EBITDA rose, but its margin declined to 21% for the first half from 23%.
- Commissions and compensation, other operating expenses, amortization and acquisition-related fair-value expense increased. The $6.2 million first-half charge for changes in contingent consideration compared with a $3.8 million gain in the prior-year period.
- COVID-19 created uncertainty around client exposures, cancellations, new business and economic activity. BRP reported $0.3 million of incremental cancellation-reserve impact on first-half organic revenue. Management highlighted potential effects on Middle Market business and Medicare sales, including the 2021 enrollment period.
- Management provided no numerical earnings or revenue guidance. It said cash, operating cash flow and available borrowing capacity were expected to fund working capital and commitments for the foreseeable future, while noting continued acquisition activity may require additional debt or equity funding.
- BRP described customary legal claims as not expected to have a material adverse effect. Estimated contingent earnout liabilities were $78.5 million; maximum estimated exposure was $227.3 million. These valuations use significant unobservable assumptions and are subject to change.
- Disclosure controls were deemed ineffective at June 30, 2020 because four previously identified material weaknesses in internal control over financial reporting remained unresolved. BRP said it was adding accounting expertise and improving close, process and IT controls.
- Management described the business as seasonal, generally with strongest Adjusted EBITDA and margins in Q1 and weakest in Q4; acquisitions and COVID-19 may alter usual patterns.
Most important facts for investors to verify
- Whether organic growth and acquired-business contributions persist, and how COVID-19 affects cancellations, client exposures and Medicare enrollment sales.
- Acquisition integration, future acquisition spending and the funding mix; verify the effect of the July $125 million debt repayment on borrowings and liquidity.
- Earnout-liability assumptions, potential payments and the earnings impact of subsequent fair-value changes.
- Progress remediating the four material weaknesses and whether disclosure controls become effective.
- Cash-flow quality, particularly the contribution from premiums payable and other working-capital movements.